v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating (income) expenses        
Research and development $ 1,316,222 $ 9,357,444 $ 13,193,834 $ 30,892,454
General and administrative 3,657,461 3,907,090 12,265,518 12,375,567
Change in estimate for legal contingency (5,000,000) 0 (1,750,000) 0
Total operating (income) expenses (26,317) 13,264,534 23,709,352 43,268,021
Operating income (loss) 26,317 (13,264,534) (23,709,352) (43,268,021)
Other (income) expense        
Interest expense 3,299 0 8,797 0
Interest and other income, net (49,099) (418,474) (321,922) (1,609,807)
Gains from asset sales 0 (91,400) (178,200) (180,763)
Other expense 2,991 0 5,402 0
Total other (income) expense, net (42,809) (509,874) (485,923) (1,790,570)
Income (loss) before income taxes 69,126 (12,754,660) (23,223,429) (41,477,451)
Provision for income taxes 0 0 3,400 5,400
Net income (loss ) $ 69,126 $ (12,754,660) $ (23,226,829) $ (41,482,851)
Income (loss) per common share:        
Basic (in dollars per share) $ 0.01 $ (2.57) $ (4.68) $ (8.37)
Diluted (in dollars per share) $ 0.01 $ (2.57) $ (4.68) $ (8.37)
Weighted average shares of common stock outstanding used to compute income (loss) per share:        
Basic (in shares) 4,960,912 4,958,241 4,960,656 4,956,814
Diluted (in shares) 4,994,551 4,958,241 4,960,656 4,956,814

Source